High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty.


PURPOSE To test whether subconjunctival cyclosporine A (CsA) implants affect the incidence and the degree of corneal neovascularization occurring after penetrating keratoplasty. DESIGN Prospective, randomized, multicenter, controlled phase 2/3 clinical trial. The study comprised 43 trial sites in Germany, India, and the United States. PARTICIPANTS… (More)
DOI: 10.1016/j.ophtha.2014.03.016